Brivanib (alaninate) T2576
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Brivanib Alaninate is the alaninate salt of a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with potential antineoplastic activity. Brivanib strongly binds to and inhibits VEGFR2, a tyrosine kinase receptor expressed almost exclusively
CAS nr:
649735-63-7
Purity:
98%
Molecular Weight:
441,46
SMILES:
Cc1cc2c(ccc(c2F)Oc2c3c(C)c(cn3ncn2)OC[C@@H](C)OC(=O)[C@H](C)N)[nH]1
Formula:
C22H24FN5O4
Pathway:
Angiogenesis,Tyrosine Kinase/Adaptors,Angiogenesis,Tyrosine Kinase/Adaptors,Autophagy
Target:
VEGFR,VEGFR,FGFR,FGFR,Autophagy
